menu
    • menu

    Company profile for Xeris Pharmaceuticals

    NEW Drugs in Dev: 7
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Xeris is a specialty pharmaceutical company leveraging novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables. Our team is focused on creating medicines that are easier to use by leveraging our unique technology. Newly approved by the FDA, Gvoke™ leverages that technology to deliver ready-to-use solutions for patients and caregivers alike. We're a specialty pharma company,...
    Xeris is a specialty pharmaceutical company leveraging novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables. Our team is focused on creating medicines that are easier to use by leveraging our unique technology. Newly approved by the FDA, Gvoke™ leverages that technology to deliver ready-to-use solutions for patients and caregivers alike. We're a specialty pharma company, passionate about people. Our unique technology is enabling medicines to be easier to use for patients & caregivers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Xeris PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    180 N. Lasalle Chicago, IL 60601
    Telephone
    Telephone
    1-877-XERIS-37
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://xerispharma.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/xeris-pharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Xeris Biopharma to Report Q1 2026 Results on May 7
    Xeris Biopharma to Report Q1 2026 Results on May 7

    23 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260423117811/en/Xeris-Biopharma-to-Report-First-Quarter-2026-Financial-Results-on-May-7-2026

    BUSINESSWIRE
    23 Apr 2026
    Share Share
    Xeris Announces Inducement Grants Under NASDAQ Rule 5635(c)(4)
    Xeris Announces Inducement Grants Under NASDAQ Rule 5635(c)(4)

    03 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260403376311/en/Xeris-Announces-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635c4

    BUSINESSWIRE
    03 Apr 2026
    Share Share
    Xeris Biopharma Posts Record 2025 Results, Issues 2026 Outlook
    Xeris Biopharma Posts Record 2025 Results, Issues 2026 Outlook

    02 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260302553712/en/Xeris-Biopharma-Reports-Record-Performance-for-Fourth-Quarter-and-Full-Year-2025-and-Provides-Full-Year-2026-Guidance

    BUSINESSWIRE
    02 Mar 2026
    Share Share
    Xeris Bio Subsidiaries File Recorlev Patent Infringement Lawsuit
    Xeris Bio Subsidiaries File Recorlev Patent Infringement Lawsuit

    26 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260226546074/en/Xeris-Biopharma-Subsidiaries-File-Recorlev-Patent-Infringement-Lawsuit

    BUSINESSWIRE
    26 Feb 2026
    Share Share
    Xeris Biopharma Announces 2025 Results and 2026 Guidance
    Xeris Biopharma Announces 2025 Results and 2026 Guidance

    17 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260217718408/en/Xeris-Biopharma-to-Report-Full-Year-2025-Financial-Results-and-Provide-Full-Year-2026-Guidance-on-March-2-2026

    BUSINESSWIRE
    17 Feb 2026
    Share Share
    Xeris Forecasts Record 2025 Revenue For Q4 And Full Year
    Xeris Forecasts Record 2025 Revenue For Q4 And Full Year

    08 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260108889727/en/Xeris-Expects-to-Deliver-Record-Fourth-Quarter-and-Full-Year-2025-Total-Revenue

    BUSINESSWIRE
    08 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Xeris Pharmaceuticals and get a quotation

    Xeris Pharmaceuticals is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find XRS0104 bulk with DMF offered by Xeris Pharmaceuticals

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search